250 related articles for article (PubMed ID: 16651617)
1. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.
Xia JL; Dai C; Michalopoulos GK; Liu Y
Am J Pathol; 2006 May; 168(5):1500-12. PubMed ID: 16651617
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
4. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
5. α7-nAChR Knockout Mice Decreases Biliary Hyperplasia and Liver Fibrosis in Cholestatic Bile Duct-Ligated Mice.
Ehrlich L; O'Brien A; Hall C; White T; Chen L; Wu N; Venter J; Scrushy M; Mubarak M; Meng F; Dostal D; Wu C; Lairmore TC; Alpini G; Glaser S
Gene Expr; 2018 Aug; 18(3):197-207. PubMed ID: 29580318
[TBL] [Abstract][Full Text] [Related]
6. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent manner.
Wei Z; Zhao D; Zhang Y; Chen Y; Zhang S; Li Q; Zeng P; Li X; Zhang W; Duan Y; Han J; Yang X
Biochem Biophys Res Commun; 2019 Nov; 519(4):854-860. PubMed ID: 31561855
[TBL] [Abstract][Full Text] [Related]
8. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells.
He H; Mennone A; Boyer JL; Cai SY
Hepatology; 2011 Feb; 53(2):548-57. PubMed ID: 21274875
[TBL] [Abstract][Full Text] [Related]
9. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
Yang J; Liu Y
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
[TBL] [Abstract][Full Text] [Related]
10. Coffee consumption prevents fibrosis in a rat model that mimics secondary biliary cirrhosis in humans.
Arauz J; Zarco N; Hernández-Aquino E; Galicia-Moreno M; Favari L; Segovia J; Muriel P
Nutr Res; 2017 Apr; 40():65-74. PubMed ID: 28473062
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction.
Kwiecinski M; Noetel A; Elfimova N; Trebicka J; Schievenbusch S; Strack I; Molnar L; von Brandenstein M; Töx U; Nischt R; Coutelle O; Dienes HP; Odenthal M
PLoS One; 2011; 6(9):e24568. PubMed ID: 21931759
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat.
Saperstein LA; Jirtle RL; Farouk M; Thompson HJ; Chung KS; Meyers WC
Hepatology; 1994 Feb; 19(2):412-7. PubMed ID: 8294098
[TBL] [Abstract][Full Text] [Related]
13. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis.
Song M; Song Z; Barve S; Zhang J; Chen T; Liu M; Arteel GE; Brewer GJ; McClain CJ
J Pharmacol Exp Ther; 2008 May; 325(2):409-16. PubMed ID: 18299419
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.
Popov Y; Sverdlov DY; Bhaskar KR; Sharma AK; Millonig G; Patsenker E; Krahenbuhl S; Krahenbuhl L; Schuppan D
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G323-34. PubMed ID: 20056896
[TBL] [Abstract][Full Text] [Related]
15. EGF neutralization antibodies attenuate liver fibrosis by inhibiting myofibroblast proliferation in bile duct ligation mice.
Xu H; Liu L; Cong M; Liu T; Sun S; Ma H; You H; Jia J; Wang P
Histochem Cell Biol; 2020 Jul; 154(1):107-116. PubMed ID: 32180004
[TBL] [Abstract][Full Text] [Related]
16. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
Younis N; Shaheen MA; Abdallah MH
Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-β1/Smad and EMT pathways.
Chilvery S; Bansod S; Saifi MA; Godugu C
Int Immunopharmacol; 2020 Nov; 88():106909. PubMed ID: 32882664
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.
Narmada BC; Kang Y; Venkatraman L; Peng Q; Sakban RB; Nugraha B; Jiang X; Bunte RM; So PT; Tucker-Kellogg L; Mao HQ; Yu H
Hum Gene Ther; 2013 May; 24(5):508-19. PubMed ID: 23527815
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
